Dr. Foster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10800 Parkside Dr
Ste 331
Farragut, TN 37934Phone+1 865-392-3400Fax+1 865-392-3449
Education & Training
- Michigan State UniversityFellowship, Interventional Cardiology, 1997 - 1997
- Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 1994 - 1997
- University of MarylandResidency, Internal Medicine, 1991 - 1994
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1991
Certifications & Licensure
- TN State Medical License 2001 - 2025
- MD State Medical License 1993 - 1994
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
- Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) Start of enrollment: 2012 Nov 05
- ABSORB III Randomized Controlled Trial (RCT) Start of enrollment: 2012 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsEffect of Pharmacomechanical Catheter-Directed Thrombolysis on Segmental Artery Occlusions: Insights From the RESCUE Trial.Riyaz Bashir, Gregory Piazza, Brian Firth, Kenneth Ouriel, Akhilesh Sista
JACC. Advances. 2023-11-01 - 227 citationsThe Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2Menno V. Huisman, Kenneth J. Rothman, Miney Paquette, Christine Teutsch, Hans-Christoph Diener
Journal of the American College of Cardiology. 2017-02-21 - 19 citationsOne-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).Takao Ohki, John F. Angle, Hiroyoshi Yokoi, Michael R. Jaff, Jeffrey J. Popma
Journal of Vascular Surgery. 2016-02-01
Press Mentions
- Tennova Turkey Creek Celebrates Milestone Cardiovascular ResearchSeptember 7th, 2021
- Endovascular Engineering Treats First Patient in Trial of Hēlo SystemFebruary 22nd, 2024
- Endovascular Engineering Begins ENGULF Pivotal Trial of Helo PE Thrombectomy SystemFebruary 23rd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: